Evidence map›Paper›PMID 42169022›Full record

ArticleThyroid research2026

Thyroid hormone measurement items in patients with Hashimoto's thyroiditis on levothyroxine monotherapy: management based on thyroid tissue volume.

Mitsuru Ito, Yoshiki Furumura, Itaru Monno, Hanna Deguchi-Horiuchi, Chisako Imamura, Sawako Takahashi, Hiroyuki Yamaoka, Mako Hisakado, Kazuyoshi Kohsaka, Eijun Nishihara and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Thyroid research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mitsuru ItoCenter for Excellence in Thyroid Care, Kuma Hospital, 8-2-35 Shimoyamate-Dori, Chuo-Ku, Kobe, Hyogo, 650-0011, Japan. ito02@kuma-h.or.jp.
Yoshiki FurumuraCenter for Excellence in Thyroid Care, Kuma Hospital, 8-2-35 Shimoyamate-Dori, Chuo-Ku, Kobe, Hyogo, 650-0011, Japan.
Itaru MonnoCenter for Excellence in Thyroid Care, Kuma Hospital, 8-2-35 Shimoyamate-Dori, Chuo-Ku, Kobe, Hyogo, 650-0011, Japan.
Hanna Deguchi-HoriuchiCenter for Excellence in Thyroid Care, Kuma Hospital, 8-2-35 Shimoyamate-Dori, Chuo-Ku, Kobe, Hyogo, 650-0011, Japan.
Chisako ImamuraCenter for Excellence in Thyroid Care, Kuma Hospital, 8-2-35 Shimoyamate-Dori, Chuo-Ku, Kobe, Hyogo, 650-0011, Japan.
Sawako TakahashiCenter for Excellence in Thyroid Care, Kuma Hospital, 8-2-35 Shimoyamate-Dori, Chuo-Ku, Kobe, Hyogo, 650-0011, Japan.
Hiroyuki YamaokaCenter for Excellence in Thyroid Care, Kuma Hospital, 8-2-35 Shimoyamate-Dori, Chuo-Ku, Kobe, Hyogo, 650-0011, Japan.
Mako HisakadoCenter for Excellence in Thyroid Care, Kuma Hospital, 8-2-35 Shimoyamate-Dori, Chuo-Ku, Kobe, Hyogo, 650-0011, Japan.
Kazuyoshi KohsakaCenter for Excellence in Thyroid Care, Kuma Hospital, 8-2-35 Shimoyamate-Dori, Chuo-Ku, Kobe, Hyogo, 650-0011, Japan.
Eijun NishiharaCenter for Excellence in Thyroid Care, Kuma Hospital, 8-2-35 Shimoyamate-Dori, Chuo-Ku, Kobe, Hyogo, 650-0011, Japan.
Shuji FukataCenter for Excellence in Thyroid Care, Kuma Hospital, 8-2-35 Shimoyamate-Dori, Chuo-Ku, Kobe, Hyogo, 650-0011, Japan.
Mitsushige NishikawaCenter for Excellence in Thyroid Care, Kuma Hospital, 8-2-35 Shimoyamate-Dori, Chuo-Ku, Kobe, Hyogo, 650-0011, Japan.
Akira MiyauchiSurgery, Kuma Hospital, Kobe, Hyogo, Japan.
Takashi AkamizuCenter for Excellence in Thyroid Care, Kuma Hospital, 8-2-35 Shimoyamate-Dori, Chuo-Ku, Kobe, Hyogo, 650-0011, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe have demonstrated that mild suppression of thyrotropin (TSH) using levothyroxine (LT

methodsIn this retrospective study, we aimed to evaluate the composition of thyroid hormone measurement items (serum FT

resultsWe identified 7,576 consecutive patients from their medical records. These patients were classified into five groups based on TV: atrophic thyroid (TV ≤ 10 mL); normal thyroid (TV 10-20 mL); mildly enlarged thyroid (TV 20-50 mL); moderately enlarged thyroid (TV 50-80 mL); and large thyroid (TV > 80 mL). In all patient groups, FT

conclusionThis study revealed that FT

Indexed as

Hashimoto thyroiditisLevothyroxineThyrotropinThyroxineTriiodothyronine

Identifiers

PMID42169022
PMCPMC13397601

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.